TRT and Blood Donation: What You Need to Know Before You Give

Why TRT Raises Your Red Blood Cell Count

Testosterone directly stimulates the kidneys to produce erythropoietin (EPO), the hormone that tells bone marrow to make more red blood cells. More red blood cells mean a higher hematocrit, the fraction of whole blood occupied by those cells. In healthy men without TRT, hematocrit sits between 41% and 53% [1]. TRT shifts that range upward in a dose-dependent way.

A 2017 meta-analysis published in The Journal of Clinical Endocrinology and Metabolism examined 51 randomized controlled trials of testosterone therapy and found that testosterone significantly increased hematocrit compared to placebo, with polycythemia (hematocrit above 54%) occurring in roughly 5.7% of treated men [2]. Intramuscular injections of testosterone cypionate or enanthate, which create higher peak serum testosterone levels, produce steeper hematocrit rises than transdermal gels or subcutaneous pellets at equivalent average doses [3].

The mechanism matters for blood donation because a unit drawn from someone with a hematocrit of 58% delivers far more red blood cells per volume than a unit drawn from someone at 46%. Transfusion centers calibrate dosing for recipients based on standard hematocrit ranges, so a high-hematocrit unit can inadvertently over-transfuse a patient receiving it for anemia.

Clinically, sustained hematocrit above 54% raises whole-blood viscosity, which may increase the risk of venous thromboembolism, stroke, and major adverse cardiovascular events [4]. The American Urological Association (AUA) 2018 guideline on testosterone deficiency states: "Clinicians should monitor hematocrit prior to, at 3 to 6 months after initiating testosterone therapy, and then annually" [5].

Blood Donation Eligibility for Men on TRT

Most men on TRT are not automatically disqualified from donating whole blood. The short answer is nuanced. The FDA and AABB (formerly the American Association of Blood Banks) do not list testosterone as a deferent drug per se, but they do require that every donor's hematocrit be below 56% at the time of donation [6].

Here is how eligibility typically works in practice, depending on hematocrit at screening:

Hematocrit <54%: You pass the standard hemoglobin or hematocrit screen (centers accept donors with hemoglobin above 12.5 g/dL or hematocrit above 38%) and your unit enters the general supply, provided no other deferrals apply. Your TRT use alone does not flag the unit.

Hematocrit 54 to 55%: You are borderline. Some centers accept the donation; others defer based on internal policy. The donated unit may be quarantined pending medical review.

Hematocrit above 55 to 56%: Most AABB-accredited centers defer the donation on hematocrit grounds alone, regardless of TRT status [6]. You will be asked to follow up with your physician before the next attempt.

Beyond hematocrit, some blood centers add a policy deferral for donors using compounded testosterone (a common form in TRT clinics) because compounded drugs are not FDA-approved finished products. The policy varies by center. Always call ahead and disclose your medication list honestly.

What happens to the unit if you do donate? Blood centers are not obligated to inform donors that their unit was discarded rather than transfused. A unit deferred after collection for hematocrit reasons is typically destroyed. That is a resource waste and the main ethical reason TRT patients should not rely on whole-blood donation as a substitute for therapeutic phlebotomy.

Therapeutic Phlebotomy vs. Standard Blood Donation

Therapeutic phlebotomy is a medical procedure ordered by a physician to remove a specific volume of blood for the purpose of reducing red blood cell mass. The mechanics look identical to donation: a 16-gauge needle, 450 to 500 mL removed, 10 to 15 minutes of draw time. The important differences are legal, clinical, and practical [7].

Standard donation requires your blood to be usable for a recipient. Therapeutic phlebotomy is purely about your physiology. No transfusion center is required to accept or credit the removed blood toward the general supply, though some do under specific "therapeutic donor" programs.

From a clinical standpoint, therapeutic phlebotomy reduces hematocrit by approximately 3, 4 percentage points per session in a 70 kg man. If your hematocrit is 58% and your target is 50%, you may need two sessions spaced 4 to 8 weeks apart [8]. Your TRT provider should order a complete blood count (CBC) with differential before and 4 weeks after each session to track response.

The AUA guideline recommends dose reduction or temporary TRT discontinuation as the first response to hematocrit above 54%, with phlebotomy reserved for cases where dose reduction alone is insufficient [5]. Talk to your prescribing clinician before scheduling phlebotomy independently.

One more practical point: some insurance plans cover therapeutic phlebotomy under ICD-10 code D75.1 (secondary polycythemia) when ordered by a physician. A self-referred visit to a blood donation center does not generate this code and will not be covered.

How Fast Does TRT Affect Hematocrit (and Other Blood Markers)?

Hematocrit typically starts rising within 6 to 8 weeks of initiating TRT and reaches its new steady state somewhere between 3 and 6 months [9]. The trajectory is not linear. Men with baseline hematocrit above 48% are at higher baseline risk of crossing the 54% threshold by month 3.

Red blood cell changes are not the only blood metric to watch. A 2020 review in Andrology tracked multiple laboratory markers in men starting testosterone therapy and reported that:

• Hemoglobin rose by a mean of 1.0 g/dL within 3 months in hypogonadal men given injectable testosterone [9].
• Hematocrit rose by a mean of 3.2 percentage points at 6 months across injection-based protocols.
• Serum ferritin may drop over time as iron is consumed building new red blood cells, which could mask iron-deficiency anemia on standard panels.

These timelines matter for donation planning. If you just started TRT, your hematocrit at 4 weeks may still be normal, but at 6 months it could disqualify you. Recheck your labs before every donation attempt.

Can You Stop TRT Cold Turkey Before Donating?

Some men consider stopping TRT temporarily to lower hematocrit before a scheduled donation. This is not recommended without physician guidance. Abrupt discontinuation of testosterone does not drop hematocrit quickly. Red blood cells live approximately 120 days [10]. Stopping TRT today means your body stops stimulating new RBC production, but the existing elevated red cell mass persists for weeks to months.

Stopping TRT cold turkey does, however, cause a rapid fall in serum testosterone, usually within 7 to 14 days for injectable esters like testosterone cypionate (half-life approximately 8 days) [11]. Hypogonadal symptoms, including fatigue, low libido, mood disturbance, and loss of lean mass, return within 2 to 4 weeks in most men whose endogenous production was suppressed [12].

If hematocrit management is the primary goal, TRT dose reduction is more effective and better tolerated than full cessation. Your prescriber may cut your weekly testosterone cypionate dose from 100 mg to 50 mg and recheck hematocrit at 8 weeks rather than stopping entirely.

Alcohol, TRT, and Blood Viscosity: A Compounding Risk

Alcohol does not directly raise hematocrit, but it compounds the cardiovascular risk profile that already comes with TRT-related erythrocytosis. Ethanol is a vasodilator acutely, which may give a transient drop in blood pressure, but regular or heavy use elevates triglycerides, suppresses testosterone production at the hypothalamic-pituitary axis, and impairs the liver's ability to clear clotting factors [13].

A cross-sectional analysis published in Alcoholism: Clinical and Experimental Research found that men consuming more than 14 standard drinks per week had measurable suppression of luteinizing hormone (LH) and total testosterone, even while on exogenous testosterone therapy, suggesting that alcohol may blunt TRT efficacy at higher intakes [13]. That suppression matters less for men on full replacement, but the cardiovascular co-risk does not disappear.

For men managing elevated hematocrit on TRT, the American Heart Association recommends limiting alcohol to no more than 2 standard drinks per day, with less being better in those with cardiovascular risk factors [14]. A drink here means 14 g of ethanol (12 oz regular beer, 5 oz wine, or 1.5 oz distilled spirits). At elevated hematocrit, blood is already more viscous; adding alcohol-driven endothelial dysfunction is worth avoiding.

TRT and Supplements That Affect Blood Cell Counts

Several commonly used supplements interact with TRT in ways that directly affect donation eligibility and hematocrit management [15].

Iron supplements: Testosterone drives erythropoiesis, which consumes iron. Some men on TRT develop low ferritin. Taking supplemental iron on top of TRT can accelerate RBC production beyond what EPO signaling alone achieves, pushing hematocrit higher. Unless a physician has confirmed iron-deficiency anemia with a serum ferritin below 30 ng/mL, iron supplementation is not appropriate for men on TRT [15].

Creatine monohydrate: Creatine does not raise hematocrit, but it does increase serum creatinine by a small amount, which may superficially suggest reduced kidney function on standard panels. Tell your lab about creatine use when interpreting metabolic panels [16].

Vitamin B12 and folate: Both are required for normal red blood cell maturation. Supraphysiologic supplementation with B12 (above 1 to 000 mcg/day) does not independently cause polycythemia in most men, but deficiencies in either can mask rising hematocrit by impairing RBC quality metrics on a CBC [17].

Whey protein and BCAAs: No direct effect on hematocrit. No donation deferral triggered.

Ashwagandha (Withania somnifera): A 2019 randomized controlled trial in Medicine (N=57) found that 600 mg/day of ashwagandha root extract raised serum testosterone by 14.7% over 8 weeks in resistance-trained men [18]. If ashwagandha is raising endogenous testosterone, it may contribute modestly to EPO stimulation and hematocrit rise in men who also take TRT.

Always bring a complete supplement list to your TRT provider appointment. "Natural" does not mean inert on a blood panel.

Monitoring Schedule for TRT Patients Who Want to Donate

The following monitoring protocol reflects current AUA and Endocrine Society recommendations, adapted for men who wish to stay eligible for whole-blood donation [5] [19]:

Before starting TRT: Baseline CBC, comprehensive metabolic panel (CMP), PSA, lipid panel. Record your baseline hematocrit.

At 3 months: Repeat CBC. If hematocrit is above 52%, discuss dose adjustment before hematocrit crosses the 54% threshold.

At 6 months: Repeat CBC plus serum ferritin. If hematocrit remains below 54% and ferritin is adequate, recheck at 12 months. You may attempt blood donation if your hematocrit at the time of donation is below 55%.

Annually thereafter: CBC, CMP, testosterone (total and free), SHBG, PSA. Hematocrit trends upward slowly in some men even at stable TRT dose, so the annual check is not optional.

Before any blood donation attempt: Request a CBC within 30 days of your planned donation date. Walk into the donation center with your current hematocrit value in hand. Most centers will still perform their own finger-stick test, but knowing your number reduces the chance of a wasted trip.

What the Data Say About Cardiovascular Risk at High Hematocrit

The TRAVERSE trial (N=5,246 men with hypogonadism and established or high risk for cardiovascular disease) published in The New England Journal of Medicine in 2023 found that testosterone therapy was noninferior to placebo for major adverse cardiovascular events (MACE) over a median 33-month follow-up, with a hazard ratio of 0.96 (95% CI 0.78, 1.17) [20]. The trial did not find that TRT caused excess heart attacks or strokes at the population level.

However, TRAVERSE also found that pulmonary embolism occurred in 0.9% of testosterone-treated men vs. 0.5% of placebo-treated men, a statistically significant difference (P<0.05) [20]. The investigators noted that erythrocytosis (hematocrit above 54%) occurred in 6.6% of the testosterone group vs. 1.5% of placebo. Hematocrit management, then, is not a cosmetic concern. It maps directly onto the one cardiovascular risk signal that TRAVERSE found to be significant.

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We suggest that clinicians aim to maintain hematocrit below 54% in men receiving testosterone therapy" [19]. That target also conveniently keeps most men eligible for whole-blood donation on hematocrit grounds.

Practical Steps Before Your Next Donation Appointment

1. Get a CBC within 30 days. Know your hematocrit number before you walk in.
2. Disclose your TRT to the donation center staff, including the drug name, dose, and administration route (injection, gel, pellet).
3. Ask whether the center participates in a therapeutic donor program. Some centers will credit your phlebotomy toward therapeutic purposes and issue you a receipt for insurance reimbursement.
4. If your hematocrit is above 54%, call your TRT provider before scheduling any phlebotomy. Do not self-refer to a donation center and call it therapeutic phlebotomy for insurance purposes without a physician order.
5. Recheck your hematocrit 4 to 6 weeks after any phlebotomy session to confirm the desired drop has occurred.
6. Do not take iron supplements in the 30 days before donation unless your physician has confirmed iron deficiency on labs.

If your hematocrit at the donation center is above 55% on the day of the draw, your donation will be deferred. That result goes into the national blood donor registry and may flag future attempts. Showing up with current labs prevents that outcome.